Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Transplants for MDS and quality-of-life. But whose quality-of-life?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. El-Jawahri A, Kim HT, Steensma DP, Cronin AM, Stone RM et al. Does quality of life impact the decision to pursue stem cell transplantation for elderly patients with advanced MDS? Bone Marrow Transplant 2016, (e-pub ahead of print 21 March 2016; doi:10.1038/bmt.2016.40).

    Article  CAS  Google Scholar 

  2. Scott BL, Pasquini MC, Logan B, Wu J, Devine S, Porter D et al Results of a phase-III randomized, multi-center study of allogeneic stem cell transplantation after high versus reduced intensity conditioning in patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0901. Available at: https://ash.confex.com/ash/2015/webprogram/Paper87386.html. (accessed on 23 March 2016).

  3. Koreth J, Pidala J, Perez WS, Deeg HJ, Garcia-Manero G, Malcovati L et al. Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis. J Clin Oncol 2013; 31: 2662–2670.

    Article  Google Scholar 

  4. Cutler CS, Lee SJ, Greenberg P, Deeg HJ, Pérez WS, Anasetti C et al. A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. Blood 2004; 104: 579–585.

    Article  CAS  Google Scholar 

  5. Cary CK, Punnen S, Odisho AY, Litwin MS, Saigal CS, Cooperberg MR et al. Nationally-representative trends and geographic variation in treatment of localized prostate cancer: the urologic diseases in America project. Prostate Cancer Prostatic Dis 2015; 18: 149–154.

    Article  CAS  Google Scholar 

  6. Christakis NA, Lamont EB . Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study. BMJ 2000; 320: 469–472.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Professors Teresa Hahn (Roswell Park Cancer Centre), Eli Estey (University of Washington), Giovanni Barosi (University of Pavia), Heidi Klepin (Wake Forest University), Cory Cutler and John Koreth (Harvard University), and Hillard Lazarus (Case Western Reserve University) kindly reviewed the typescript. RPG acknowledges support from the National Institute of Health Research (NIHR) Biomedical Research Centre funding scheme. We failed several sensitivity-training courses while formulating this typescript. Remedial work in progress.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R P Gale.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gale, R., Pusic, I. Transplants for MDS and quality-of-life. But whose quality-of-life?. Bone Marrow Transplant 51, 1066–1068 (2016). https://doi.org/10.1038/bmt.2016.147

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2016.147

This article is cited by

Search

Quick links